-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
Satellos Bioscience Inc. | 1.180% | -1.156% | -4.469% | 8.917% | -38.929% | -10.236% | - |
Vaxart Inc. | 0.550% | -5.476% | -21.622% | -44.498% | -56.973% | -92.985% | -96.329% |
Larimar Therapeutics Inc. | 16.030% | 19.079% | 35.075% | -46.370% | -2.688% | 54.701% | -63.397% |
News

What AMD and Nvidia Shareholders Should Know About Recent China Updates
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the

What AMD, CoreWeave, and Nvidia Stock Investors Should Know About Recent Updates
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and CoreWeave (NASDAQ: CRWV). To learn more, check out the short video, consider

2 Top Artificial Intelligence Stocks to Buy Right Now
It's been another banner year for artificial intelligence (AI) stocks. As of this writing, leaders like Palantir Technologies and Advanced Micro Devices advanced 148% and 44% year to date,